Dishman CRAMS

  • Large dedicated R&D centre with multiple shift R&D operations (India)
  • Development services, kilo supply, cGMP pilot production, full scale cGMP manufacture (India, China)
  • 12 multi-purpose and dedicated production facilities for APIs, intermediates (India, China)
  • 1125 m³ dedicated API manufacturing capacity (India, China)
  • Broad range of technical skills and capabilities encompassing all routine chemistries and a wide variety of sophisticated modern technologies (India, China)

 

News

5 November 2018
Dishman Carbogen Amcis Ltd. Announces a Successful FDA Inspection of its Site in Bavla, India

1 August 2018
Dishman Carbogen Amcis Opens Office in Kyoto, Japan

11 August 2016
Dishman Celebrates a Decade of Success Since Acquisition of CARBOGEN AMCIS

VIEW NEWS ARCHIVE